<qa>  What is the name of the subject that receives a standard or investigational treatment for their- Subjects receiving any other standard or investigational treatment for their hematologic malignancy other than hydroxyurea. Subjects with CNS leukemia are eligible and may receive concurrent standard intrathecal chemotherapy. 